scholarly journals Tophaceous gout in a patient with sickle cell-thalassemia: case report and review of the literature

1983 ◽  
Vol 26 (7) ◽  
pp. 928-929 ◽  
Author(s):  
Robert D. Leff ◽  
Marlene A. Aldo-Benson ◽  
Rose Spitz Fife
Blood ◽  
1951 ◽  
Vol 6 (4) ◽  
pp. 365-371 ◽  
Author(s):  
DONALD SHOTTON ◽  
CHARLES L. CROCKETT ◽  
BYRD S. LEAVELL

Abstract 1. A case of sickle cell anemia who had numerous hemolytic crises and also hypersplenic effects such as pancytopenia was treated by splenectomy with marked improvement in general condition and in the blood. The literature relating to this subject is reviewed. Those cases with the largest spleens appear to have shown the most striking degrees of improvement. 2. In cases of sickle cell anemia showing various indications of hypersplenism, and excessive hemolysis, splenectomy may be a rational therapeutic procedure.


2003 ◽  
Vol 32 (04) ◽  
pp. 269 ◽  
Author(s):  
Issam Saliba ◽  
Alain Bouthiller ◽  
Pascal Desrochers ◽  
France Berthlet ◽  
Jean-Jacques Dufour

2017 ◽  
Vol 10 (1) ◽  
pp. 1-7 ◽  
Author(s):  
Madhumati R. Kalavar ◽  
Sami Ali ◽  
Damoun Safarpour ◽  
Saroj Davi Kunnakkat

Renal medullary carcinoma (RMC) is a rare, yet aggressive malignancy of the kidney that is found predominantly in young patients with African descent and sickle cell hemoglobinopathies and most specifically sickle cell trait. Due to its aggressive nature, most cases have metastasis or local invasion at the time of diagnosis. Prognosis is extremely poor with survival less than 1 year after diagnosis. Here we present a case of metastatic RMC in a 29-year-old African female. Despite chemotherapy with cisplatin, gemcitabine, and paclitaxel, and initial shrinkage of the tumor, the patient died 5 months after diagnosis.


2012 ◽  
Vol 39 (2) ◽  
pp. 123-126 ◽  
Author(s):  
Frederic Marinho ◽  
Delphine Zeitoun-Eiss ◽  
Jerôme Renoux ◽  
Jean-Louis Brasseur ◽  
Catherine Genestie ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document